Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 1/2021

01-01-2021 | Septicemia | IM - COMMENTARY

Interpreting procalcitonin in patients undergoing hemodialysis: a reliable or a misleading marker?

Authors: Marco Falcone, Giusy Tiseo, Francesco Menichetti

Published in: Internal and Emergency Medicine | Issue 1/2021

Login to get access

Excerpt

Biomarkers are an essential tool for the identification and monitoring of patients developing an infection, to determine their clinical severity and to assess the response to antibiotic therapy [1]. However, the interpretation of procalcitonin (PCT) values may be challenging in subjects undergoing hemodialysis (HD), and several considerations about the use of PCT in HD patients should be done. …
Literature
1.
Hamade B, Huang DT (2020) Procalcitonin: where are we now? Crit Care Clin 36:23–40CrossRef
2.
3.
Kofoed K, Andersen O, Kronborg G et al (2007) Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 11:R38CrossRef
4.
Naeini AE, Montazerolghaem S (2006) Procalcitonin marker for sepsis diagnosis. Evaluating a rapid immuno-chromatografic test. Saudi Med J 27:422–424PubMed
5.
Jimeno A, García-Velasco A, del Val O et al (2004) Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer 100:2462–2469CrossRef
6.
Oshita H, Sakurai J, Kamitsuna M (2010) Semi-quantitative procalcitonin test for the diagnosis of bacterial infection: clinical use and experience in Japan. J Microbiol Immunol Infect 43:222–227CrossRef
7.
Clec'h C, Fosse JP, Karoubi P et al (2006) Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 34:102–107CrossRef
8.
Dorizzi RM, Polati E, Sette P, Ferrari A, Rizzotti P, Luzzani A (2006) Procalcitonin in the diagnosis of inflammation in intensive care units. Clin Biochem 39:1138–1143CrossRef
9.
Gaïni S, Koldkjaer OG, Pedersen C, Pedersen SS (2006) Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 10:R53CrossRef
10.
Tsangaris I, Plachouras D, Kavatha D et al (2009) Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay. BMC Infect Dis 22(9):21
11.
Brys ADH, Di Stasio E, Lenaert B et al (2020) Serum interleukin-6 and endotoxin levels and their relationship with fatigue and depressive symptoms in patients on chronic haemodialysis. Cytokine 125:154823CrossRef
12.
Nijsten MW, Olinga P, The TH et al (2000) Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 28:458–461CrossRef
13.
Mori K, Noguchi M, Sumino Y, Sato F, Mimata H (2012) Use of procalcitonin in patients on chronic hemodialysis: procalcitonin is not related with increased serum calcitonin. ISRN Urol 2012:431859PubMedPubMedCentral
14.
Falcone M, Tiseo G, Dentali F et al (2018) Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli. Eur J Intern Med 53:21–28CrossRef
15.
Falcone M, Russo A, Iacovelli A et al (2016) Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin Microbiol Infect 22:444–450CrossRef
16.
Falcone M, Tiseo G, Gutiérrez-Gutiérrez B et al (2019) Impact of initial antifungal therapy on the outcome of patients with candidemia and septic shock admitted to medical wards: a Propensity Score-adjusted analysis. Open Forum Infect Dis 6:fz251CrossRef
17.
Falcone M, Bassetti M, Tiseo G et al (2020) Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care 24:29CrossRef
18.
Schuetz P, Maurer P, Punjabi V, Desai A, Amin DN, Gluck E (2013) Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care 17:R115CrossRef
19.
Montagnana M, Lippi G, Tessitore N et al (2009) Procalcitonin values after dialysis is closely related to type of dialysis membrane. Scand J Clin Lab Invest 69:703–707CrossRef
20.
Kubo S, Iwasaki M, Horie M et al (2019) Biological variation of procalcitonin levels in hemodialysis patients. Clin Exp Nephrol 23:402–408CrossRef
21.
Chastre J, Wolff M, Fagon JY et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290:2588–2598CrossRef
22.
Wirz Y, Meier MA, Bouadma L et al (2018) Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials. Crit Care 22:191CrossRef
23.
Tiseo G, Mazzone A, Falcone M (2019) Identifying patients with acute bacterial skin and skin structure infection who need blood cultures. Intern Emerg Med 14:203–206CrossRef
Metadata
Title
Interpreting procalcitonin in patients undergoing hemodialysis: a reliable or a misleading marker?
Authors
Marco Falcone
Giusy Tiseo
Francesco Menichetti
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 1/2021
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-020-02341-z

Other articles of this Issue 1/2021

Internal and Emergency Medicine 1/2021 Go to the issue

EM - REVIEW

Diagnosis and management of acute aortic syndromes in the emergency department

CE - MEDICAL ILLUSTRATION

An unusual cause of large bowel perforation: ingestion of a clam valve

CE - LETTER TO THE EDITOR

In a patient with shock, melena can be much delayed

CE-Systematic reviews and meta-analysis

TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis

IM - ORIGINAL

Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction

CE - LETTER TO THE EDITOR

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?: Comment
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits